Literature DB >> 7277182

Binding of several loop diuretics to serum albumin and human serum from patients with renal failure and liver disease.

S Goto, H Yoshitomi, A Miyamoto, K Inoue, M Nakano.   

Abstract

The binding of the new diuretic piretanide and two other diuretics (furosemide and bumetanide) to serum proteins (especially albumin) was studied using the in vitro equilibrium dialysis method. Piretanide and bumetanide, similar to each other in chemical structure, were almost equal in the binding constant to purified albumin, while the binding constant of furosemide was greater than that of the other two diuretics. The binding of these loop diuretics in the dilutions of the sera from healthy adults and patients with renal failure or liver disease was also studied by the same method. Protein binding of the drugs was markedly reduced in patients with renal failure. The cause could only partly be explained by some structural changes in the serum albumin molecules of these patients and influences of endogeneous substances present in serum.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7277182     DOI: 10.1248/bpb1978.3.667

Source DB:  PubMed          Journal:  J Pharmacobiodyn        ISSN: 0386-846X


  6 in total

1.  Mode of interaction of loop diuretics with human serum albumin and characterization of binding site.

Authors:  N Takamura; A Haruta; H Kodama; M Tsuruoka; K Yamasaki; A Suenaga; M Otagiri
Journal:  Pharm Res       Date:  1996-07       Impact factor: 4.200

Review 2.  The efficacy of diuretics in acute and chronic renal failure. Focus on torasemide.

Authors:  T Risler; B Krämer; G A Müller
Journal:  Drugs       Date:  1991       Impact factor: 9.546

Review 3.  Hypertension: the missing WNKs.

Authors:  Hashem A Dbouk; Chou-Long Huang; Melanie H Cobb
Journal:  Am J Physiol Renal Physiol       Date:  2016-03-23

Review 4.  Bumetanide. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use.

Authors:  A Ward; R C Heel
Journal:  Drugs       Date:  1984-11       Impact factor: 9.546

Review 5.  NKCC1: Newly Found as a Human Disease-Causing Ion Transporter.

Authors:  Rainelli Koumangoye; Lisa Bastarache; Eric Delpire
Journal:  Function (Oxf)       Date:  2020-11-03

6.  Conformational distortion in a fibril-forming oligomer arrests alpha-Synuclein fibrillation and minimizes its toxic effects.

Authors:  Ritobrita Chakraborty; Sandip Dey; Pallabi Sil; Simanta Sarani Paul; Dipita Bhattacharyya; Anirban Bhunia; Jayati Sengupta; Krishnananda Chattopadhyay
Journal:  Commun Biol       Date:  2021-05-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.